AUTOSTAT II ANTI-CARDIOLIPIN IGM ELISA— 510(k) K992449

Name: FDA 510(k) clearance K992449
Creator: U.S. Food and Drug Administration
Published: 1999-11-24

Substantially Equivalent

Cogent Diagnotics , Ltd.

FDA 510(k) clearance K992449 for AUTOSTAT II ANTI-CARDIOLIPIN IGM ELISA, Substantially Equivalent on 1999-11-24. Applicant: Cogent Diagnotics , Ltd.. Device class: 2.

Clearance details

Applicant: Cogent Diagnotics , Ltd.
Product code: Code MID
Device class: Class 2
Regulation: 21 CFR 866.5660
Advisory panel: Immunology
Date received: 1999-07-22
Decision date: 1999-11-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Midlothian, Scotland, GB

Download summary PDF View on FDA.gov ↗

Recent devices under product code MID

view all

K223093 — Aptiva APS IgG Reagent; Aptiva APS IgM Reagent2024-12-17
K131821 — ELIA(TM) CARDIOLIPIN IGA IMMUNOASSAY2013-12-23
K130528 — BIOPLEX 2200 APLS IGM2013-10-21
K120817 — QUANTA FLASH ACL LGA, QUANTA FLASH B2GP1 IGA2013-02-26
K113020 — IMMULISA ENHANCED (TM) CARDIOLIPIN IGA, IGG, IGM AND IGA/IGG/IGM ANTIBODY (ACA) ELISAS2012-10-25

More clearances from Cogent Diagnotics , Ltd.

view all

K003054 — AUTOSTAT II ENA-6 PROFILE ELISA2000-10-13
K003057 — AUTOSTAT II ENA-4 PROFILE ELISA2000-10-13
K002215 — AUTOSTAT II ANTI-MYELOPEROXIDASE (MPO) ELISA2000-09-28
K993557 — AUTOSTAT II RHEUMATOID FACTOR IGA ELISA2000-03-03
K994338 — AUTOSTAT II RHEUMATOID FACTOR IGM ELISA2000-02-03

Data sourced from openFDA. This site is unofficial and independent of the FDA.